PharmaShots | Incisive News in 3 Shots

Subscribe Now

IASO Bio

IASO Bio and Innovent’s CT103A/ IBI326 Receive the US FDA’s Orphan Drug Designation for Multiple Myeloma

IASO Bio and Innovent’s CT103A/ IBI326 Receive the US FDA’s Orphan Drug Designation for Multiple Myeloma

February 14, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us